Study

A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. – Cost Effective Supplements

A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/12196747


Conclusion of this study

In men with AGA, 5% topical minoxidil was clearly superior to 2% topical minoxidil and placebo in increasing hair regrowth, and the magnitude of its effect was marked (45% more hair regrowth than 2% topical minoxidil at week 48). Men who used 5% topical minoxidil also had an earlier response to treatment than those who used 2% topical minoxidil. Psychosocial perceptions of hair loss in men with AGA were also improved. Topical minoxidil (5% and 2%) was well tolerated by the men in this trial without evidence of systemic effects.


Supplements analyzed in this study

Minoxidil

Health conditions analyzed in this study

Hair Loss


Moderately Positive
Minoxidil


Functions related to this study

Skin, hair and nails


Moderately Positive
Minoxidil


Body systems related to this study


Integumentary system
Scroll to top